BRD4 represses CBX5
Ontology highlight
ABSTRACT: BRD4 is amplified and/or up-regiulated in a subset of ovarian cancer which correlates with a poor survival siRNA sensitization screens in the presence of CHK1 inhibitor, LY2606368, identify BRD4 as a therapeutic target in ovarian cancer. BRD4 suppression by either siRNA or using JQ1 increases CBX5 expression
ORGANISM(S): Homo sapiens
PROVIDER: GSE78704 | GEO | 2016/05/01
SECONDARY ACCESSION(S): PRJNA313265
REPOSITORIES: GEO
ACCESS DATA